Five-Year Safety Study Examines The Effect Of LANTUS® On The Progression Of Retinopathy In People With Type 2 Diabetes | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Thursday, June 12, 2008

Email

Comments

PharmaLive

PARIS, June 10, 2008: A five-year safety study designed to assess the risk of exacerbation of diabetes-related retinopathy in patients with type 2 diabetes treated with LANTUS® (insulin glargine [rDNA origin] injection) showed similar progression of retinopathy for LANTUS® compared to NPH insulin.

Retina Products and Equipment »

Which of the following methods of pupil enlargement is least effective for poor dilation due to Flomax:
1. Intraocular epinephrine
2. Iris hooks
3. Healon 5
4. Manual iris stretching
Check The Answer

Volk iNview
iPhone Fundus Camera The Volk iNview ... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us